Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.
about
Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapyAlternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptorThe Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping testsStructural and functional similarity of amphibian constitutive androstane receptor with mammalian pregnane X receptorPharmGKB summary: cyclosporine and tacrolimus pathwaysCarboxymefloquine, the major metabolite of the antimalarial drug mefloquine, induces drug-metabolizing enzyme and transporter expression by activation of pregnane X receptor.Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Expression and regulation of human fetal-specific CYP3A7 in miceGenome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypesThe pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?Differential effects of clinically used derivatives and metabolites of artemisinin in the activation of constitutive androstane receptor isoformsClinical implications of CYP3A polymorphisms.PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity.Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.A pharmacogenomics primer.Role of Chromatin Structural Changes in Regulating Human CYP3A Ontogeny.Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma.Association of genotypes of the CYP3A cluster with midazolam disposition in vivo.Pharmacogenomics of CYP3A: considerations for HIV treatment.Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patientsMolecular population genetics of human CYP3A locus: signatures of positive selection and implications for evolutionary environmental medicine.The Making of a CYP3A Biomarker Panel for Guiding Drug Therapy.CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites.CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy.Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations.Cytochrome P450 pharmacogenetics in African populations.Human pregnane X receptor is activated by dibenzazepine carbamate-based inhibitors of constitutive androstane receptor.Effects of atorvastatin metabolites on induction of drug-metabolizing enzymes and membrane transporters through human pregnane X receptor.Marmoset CYP3A21, a model for human CYP3A4: protein expression and functional characterization of the promoter.A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression.Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometry.The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR).Ontogeny of CYP3A and P-glycoprotein in the liver and the small intestine of the Göttingen minipig: an immunohistochemical evaluation.A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1.Genome-wide association study of offspring birth weight in 86,577 women identifies five novel loci and highlights maternal genetic effects that are independent of fetal genetics.Influence of CYP3A and ABCB1 polymorphisms on cyclosporine concentrations in renal transplant recipients.The effect of fetal androgen metabolism-related gene variants on external genitalia virilization in congenital adrenal hyperplasia.Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery.Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.
P2860
Q24676890-003E8B5F-6A3C-4DF9-A4F0-9F6A8BF7DC76Q24797407-A1EAA3E6-4422-40F8-ABBC-DEF1E702593AQ26741187-F0C7C18C-6FE6-401F-BEF7-0C6B251B13C0Q28260518-17A80325-2837-4AEE-8257-9DC69DACB547Q28538476-B1C15005-ABA0-4E98-A390-23FE5F7F10C4Q33989902-E8A4CD82-9B47-40EF-8D14-2668E1A12DF1Q34921957-B21C1FB7-CD77-4B89-9795-3F7525C42406Q35179692-46D1F829-878B-4D8D-8725-50940DC7EA24Q35762696-D8184E81-6B60-45E4-9471-2E11E439E94EQ36045132-71BDBE80-25DF-4DA6-9DE0-E21528F23659Q36186945-D12236A8-D543-481D-B51B-B5E6A6160E6FQ36254041-B81183F1-8FC5-4BFA-9DFC-6C10D5A3D90BQ36546247-EB4D7224-6D3E-4800-A56A-9EAAE2B5D7EEQ36551142-F474A401-EAFB-4E3A-8652-5EDFE6F0F078Q36696957-F8E65F31-B153-4832-B97C-EB26A604F2F2Q36896796-D0E22E32-FC71-41DF-8186-20CF414F72C1Q37062637-A595CB3D-FAA3-4C1E-9AA1-8B4BB30EFB67Q37067431-60B187A4-236E-4EE8-94F8-50B3A6B57151Q37359687-82DD4AE2-1F97-49AA-B6FF-2F710593AFB2Q37419542-FF252FA0-763B-4871-A0D2-42D5C60C5F84Q37439873-EF1A19B1-0A7C-488B-80FE-7E1A24968C62Q37465914-C774AB11-9927-4483-AF5E-B34F82856294Q37513374-DD35C889-C83A-4EBA-B3AD-68599536B768Q37627774-81E72BC3-4A60-4334-874C-F57DAE04FC30Q38068539-EFF62DC2-9B95-44AA-8444-0D5090E8F5F3Q38086777-2DF7BC90-8F16-456D-8D92-E92ADEEDE485Q38099372-7CF73E10-0DDA-4E04-B61C-64DBD4558873Q38910106-89DAAA1C-BDC3-49A9-A6E1-88BF91BCAC76Q39474573-35A56032-9655-4258-8D6E-9EE0D8BB4969Q40197753-763BB75C-4E6D-4715-A6A5-35AB755EBAB6Q40399800-DADBEBD7-11E4-448D-8701-18C89F6B4C97Q42123786-2BA01295-0FCE-400B-A4B7-DC3C434BD84FQ44976819-1715F6CC-B1B1-44D3-BBFE-63FA75B5FB55Q45400881-76CCC7AA-8FDA-41C3-8DFA-7D9022AA00F7Q46529262-5ABB6882-C69E-447F-B75E-4F93E7C9747FQ47172157-88C3053C-2D39-4CA4-9021-7B1B5B00ACD7Q49792894-0ED0C4FD-DA54-4354-A1E0-DC00EC2BB4BDQ50058352-8E4DDBEB-24A8-404A-9BEF-BD3CC662AFBFQ50179674-28380ED6-69D4-4450-B0F4-38EE25C381F3Q50534806-CBD79511-FDD2-4389-99E8-06F9B65A7655
P2860
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.
@en
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.
@nl
type
label
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.
@en
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.
@nl
prefLabel
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.
@en
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.
@nl
P2093
P2860
P356
P1476
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.
@en
P2093
Andreas K Nuessler
Elisabeth Hustert
Hartmut Glaeser
Heike Tegude
Kathrin Klein
Leszek Wojnowski
Martin F Fromm
Michel Eichelbaum
Oliver Burk
P2860
P304
24280-24288
P356
10.1074/JBC.M202345200
P407
P577
2002-04-08T00:00:00Z